HIV & You
Counselling Guidelines for HIV Testing
 


Components of Pretest Counselling


Principles

Pretest counselling is an educational opportunity and should be viewed as a means to initiate preventive and continuing care. The decision to be tested should always be the choice of the individual patient. More than one pretest counselling session may be required for patients who refuse testing or are unprepared for testing. (See Pointers for counsellors.)

Assess the person's risk of HIV infection

Assess risk by asking simple, open-ended questions such as:
  • To enable you and me to understand your risk of HIV infection better, may I ask you some specific questions?
  • Has your partner, or anyone who has had sex or used drugs with your partner, been found to have HIV infection or AIDS?
  • When was the last time you had sex with a woman? With a man?
  • What kinds of sexual activities do you have?
  • How and when do you use condoms? Spermicides?
  • Do you have sex when you are using drugs or alcohol?
  • Have any of your partners had problems with alcohol or drugs?
  • When was the last time you injected drugs? Anabolic steroids?
  • Have you ever injected drugs when you were under the influence of drugs or alcohol?
  • Has someone ever injected them for you?
  • When was the last time you shared needles, "cookers" (syringes) or other drug-injecting equipment?
  • Have you ever had a sexually transmitted disease (STD)? Hepatitis?
  • Have you ever had surgery or a blood transfusion?

Assess the window period

The interval following infection and before the appearance of HIV antibodies is known as the serologic "window period." After being infected with HIV, 95% of adults and youth will produce HIV antibodies within 3 months of infection; 99% will produce antibodies within 6 months. People may prefer to be tested at 3 months, 6 months, or both, after the most recent risk event.

To determine the window period, help identify the most recent risk event (i.e., potential exposure to HIV) and plan the appropriate time of testing. If a patient is believed to be in the window period, discuss risk reduction to prevent exposure to HIV while he or she is waiting to be tested.

Provide information

Regardless of whether testing is undertaken, take advantage of this opportunity to discuss HIV infection, risk-producing activities and specific ways in which the person can avoid or reduce risk.

In providing information about HIV, physicians may use educational materials such as brochures and videotapes or refer the patient to other sources of information. Local public health units, AIDS service organizations and the National AIDS Clearinghouse can supply material to physicians for distribution. (See What the patient should know about HIV infection.)

Identify testing options available in the region

Anonymous testing
  • Usually available through special clinics.
  • The patient's only identifier is a code name or number assigned by clinic staff.
  • The identity of the patient does not have to be revealed to the physician or staff.
  • When informed by the patient of a positive test result obtained from an anonymous test site, physicians should confirm it with repeat testing and counselling.
Non-nominal testing
  • The patient's name is replaced by a code on the testing requisition (e.g., billing code, initials).
  • Only the physician and the patient know to whom the code refers.
  • Test results are included in the patient's chart and cannot be deleted.
Nominal testing
  • The name of the patient is written on the testing requisition.
  • Anyone reading these forms will know the identity of the patient tested and the test result.
  • As for non-nominal testing, results are included in the patient's chart and cannot be deleted.

Discuss record-keeping

Inform the patient that test results and information will be added to his or her medical record and will be available to other health professionals on a need-to-know basis. If the patient objects, anonymous testing should be discussed.

Unsubstantiated HIV-positive test results should not be recorded without verification.

Special identification by visual coding or tagging on the outside of HIV-positive patients' files is not recommended as it may lead to a breach of confidentiality.

Discuss the implications of testing

Take time to examine and discuss the issues raised by testing so that the patient has the opportunity to weigh the advantages and disadvantages of being tested and prepare for the potential consequences of a positive or negative test result (See Advantages, disadvantages and consequences). Testing should be carried out only when the patient considers the advantages to be greater than the disadvantages.

Discuss the confidentiality of test results in relation to office or clinic procedures, communication of results to other health care officials, partner notification and reporting requirements.

Evaluate the patient's capacity to cope with a positive test result.

Determine the timing of testing and the post-test visit

Seldom is the need to obtain HIV-test results so urgent that it must be done immediately. The patient's concerns should be examined in detail to determine whether testing is appropriate when first requested or if it should be deferred.

During the window period, serologic testing for HIV may not be accurate. Tests should take place 3 months after the most recent risk event. Help identify the most recent risk event and plan the appropriate time of testing.

Physicians should contact an experienced colleague or check with a laboratory to determine time needed for testing (turnaround time for enzyme-linked immunosorbent assay [ELISA] and confirmatory tests).

For patients who have no signs or symptoms of HIV infection and are willing to wait until the end of the window period, provide a requisition for testing 3 months after the most recent risk event. Some patients may request a baseline test for various reasons, including anxiety, occupational exposure, requirements of workers' compensation boards or in some cases of sexual assault. (When the assault carries a risk of HIV infection, blood can be drawn during the post-assault visit, if the patient agrees, to be tested or discarded later at his or her discretion.) This baseline test, if negative, cannot accurately reflect the patient's status vis-à-vis HIV infection unless a second test is done once the patient is outside the window period.

Arrange a post-test appointment, allowing enough time for confirmatory testing should it be required. Results will usually be available in 2 to 6 weeks.

Obtain and record informed consent

Encourage the person to ask any additional questions to clarify doubts or fears or to seek information. Informed consent may be verbal and need not involve a specific form. Once informed consent is expressed, it should be recorded in the patient's chart [example] (1).

Provide support and follow-up

Test results, whether positive or negative, must be given only in person, in a face-to-face interview. Informing patients of their test result by telephone is unacceptable, even when it is negative. It places the physician at risk of liability should disclosure to someone other than the patient inadvertently occur. Communicating test results face-to-face permits better appreciation of the patient's reaction and enables adequate counselling.

Patients should be encouraged to contact the physician, AIDS service organizations or support groups if they experience intolerable anxiety between the time the blood is drawn for testing and the time they receive their result.


  Continue


Go to the Counselling Guidelines Menu

Go to the Testing For HIV Menu

Go to the HIVpositive.us Main Menu

















39